Coreg and Azacitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coreg (carvedilol) and Azacitidine (azacitidine). Common drug interactions include anaemia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Coreg and Azacitidine. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

On Jul, 05, 2026

21 people who take Coreg and Azacitidine together, and have interactions are studied.

Coreg and Azacitidine drug interactions.

What are the common drug interactions of Coreg and Azacitidine, by gender? *:

female:

Anaemia (lack of blood)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Pneumonia
Fatigue (feeling of tiredness)
Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
Neutropenia (an abnormally low number of neutrophils)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)
Abnormal weight gain
Aphasia (damage to the parts of the brain that control language)

male:

Anaemia (lack of blood)
Diarrhoea
Emotional distress
Exposure to communicable disease
Eye pain
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Fungal infection
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Headache (pain in head)

What are the common drug interactions of Coreg and Azacitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Infection

60+:

Anaemia (lack of blood)
Diarrhoea
Septic shock (shock due to blood infection)
Thrombocytopenia (decrease of platelets in blood)
Abnormal weight gain
Agitation (state of anxiety or nervous excitement)
Atelectasis (partial or complete collapse of the lung)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood creatinine increased
Conjunctival haemorrhage (bleeding underneath the conjunctiva)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 38.10%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 7 people, 33.33%
Stress And Anxiety: 6 people, 28.57%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 19.05%
Diabetes: 4 people, 19.05%
Constipation: 3 people, 14.29%
Urine Output Decreased: 2 people, 9.52%
Rickets (softening of bones): 2 people, 9.52%
Multiple Myeloma (cancer of the plasma cells): 2 people, 9.52%
Fungal Infection: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and Azacitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously